EUVIMEDEUVIMED entdecken
Crossref

Prophylactic Effectiveness of Ramosetron versus Ondansetron for Preventing Postoperative Nausea and Vomiting in Adults: A Randomized Comparative Study

D Akshatha, Rashmi R Aithal, Shahbaz Haroon, M Kavya Prabhu

Annals of African Medicine · 06.04.2026

DOI: 10.4103/aam.aam_754_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of African Medicine, online erschienen am 06.04.2026. Verfasst von D Akshatha und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Postoperative nausea and vomiting remain a significant perioperative challenge affecting patient recovery and satisfaction. While 5-hydroxytryptamine type 3 receptor antagonists provide effective prophylaxis, comparative data between different agents within this class require further evaluation. This investigation examined the relative prophylactic performance of ramosetron and ondansetron in preventing postoperative emetic episodes. Materials and Methods: A prospective randomized trial was conducted involving 72 adult patients (American Society of Anesthesiologists I–II, ages 20–60 years) scheduled for elective surgery under general anesthesia. Participants were randomly allocated to receive either ramosetron 0.3 mg intravenously (Group R, n = 36) or ondansetron 4 mg intravenously (Group O, n = 36) administered 30 min before anticipated extubation. Primary outcomes included emetic episodes, requirement for rescue antiemetics, and adverse reactions during three observation periods: 0–2 h, 2–12 h, and 12–24 h postoperatively. Complete prophylactic success was defined as the absence of nausea, retching, vomiting, and rescue medication throughout the 24-h surveillance period.

Results

Demographics were comparable between the groups. Ramosetron demonstrated superior prophylactic efficacy with 92% of patients achieving a complete response compared to 58% in the ondansetron group ( P = 0.001). Early postoperative vomiting (0–2 h) occurred in 19.4% of ondansetron recipients versus 0% receiving ramosetron ( P = 0.005). Rescue antiemetic requirements were significantly higher in the ondansetron cohort during the initial 2-h period (16.7% vs. 0%, P < 0.05). Both the medications exhibited comparable safety profiles with minimal adverse effects.

Conclusions

Ramosetron provides superior prophylactic effectiveness against postoperative nausea and vomiting compared to ondansetron, particularly during the early recovery phase, while maintaining equivalent tolerability.

Schlagwörter

Stichwörter der Autor:innen

5-hydroxytryptamine type 3 antagonistsAntagonistes de la 5-hydroxytryptamine de type 3antiemeticsantiémétiquesnausées postopératoiresondansetronondansétronpostoperative nausearamosetronramosétronvomissementsvomiting

Autor:innen und Institutionen

  • Department of Anaesthesiology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Zitieren

APA

Akshatha, D., Aithal, R. R., Haroon, S., & Prabhu, M. K. (2026). Prophylactic Effectiveness of Ramosetron versus Ondansetron for Preventing Postoperative Nausea and Vomiting in Adults: A Randomized Comparative Study. Annals of African Medicine. https://doi.org/10.4103/aam.aam_754_25

Vancouver

Akshatha D, Aithal RR, Haroon S, Prabhu MK. Prophylactic Effectiveness of Ramosetron versus Ondansetron for Preventing Postoperative Nausea and Vomiting in Adults: A Randomized Comparative Study. Annals of African Medicine. 2026. doi:10.4103/aam.aam_754_25

BibTeX
@article{Akshatha2026,
  author = {Akshatha, D and Aithal, Rashmi R and Haroon, Shahbaz and Prabhu, M Kavya},
  title = {Prophylactic Effectiveness of Ramosetron versus Ondansetron for Preventing Postoperative Nausea and Vomiting in Adults: A Randomized Comparative Study},
  journal = {Annals of African Medicine},
  year = {2026},
  doi = {10.4103/aam.aam_754_25}
}
Kostenlos starten →